Spinal Fusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Spinal Fusion Devices Market by Product Type (Thoracolumbar Devices, Cervical Devices, and Interbody Fusion Devices), Indication (Degenerative Disc Disorders, Complex Deformity, Trauma & Fractures, and Others), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is estimated to grow at a remarkable CAGR forecast till 2032 owing to rising instances of spinal disorders, rising trauma and sports related injuries, increasing cases of chronic pain, and increase in product development activities among the key market players across the globe.

The spinal fusion devices market was valued at USD 7.13 billion in 2024, growing at a CAGR of 5.31% during the forecast period from 2025 to 2032 to reach USD 10.76 billion by 2032. The spinal fusion devices market is experiencing steady growth is driven by the rising instances of spinal disorders along with the growing global prevalence of chronic pain. Additionally, conditions such as degenerative disc disease, spondylolisthesis, and spinal stenosis are becoming increasingly common, particularly among the aging population. The surge in road traffic accidents further highlights the urgent need for effective spinal fusion solutions to restore mobility and reduce long-term disability. Additionally, the increase in product development activities among the key market players is further escalating the overall market of spinal fusion devices. Collectively, these factors are anticipated to fuel the expansion of the spinal fusion devices market over the forecast period from 2025 to 2032.

Spinal Fusion Devices Market Dynamics:

According to the World Health Organization (WHO) (2024), about 15.4 million people were living with spinal cord injuries globally. Most cases of spinal cord injury result from trauma, including falls or acts of violence, and are therefore preventable.

As per the data from WHO (2023), there were approximately 619 million cases of lower back pain (LBP), and it was projected that the number of LBP cases will rise to 843 million by 2050.

As per data by the European Pain Federation (2023), it was stated that 740 million people globally experience an episode of severe pain at some point in their lives on average. For approximately 20% of these individuals, the pain persists for longer than three months, thereby categorizing it as chronic pain. Thus, the growing instances of spinal cord injuries, persistent lower back pain, and chronic pain worldwide are substantially fueling the demand for spinal fusion devices. Spinal fusion becomes a preferred surgical option to relieve pain by stabilizing the affected vertebrae. Similarly, spinal cord injuries are further driving the need for spinal stabilization technologies as spinal fusion devices play a critical role in restoring structural integrity, minimizing nerve damage, and improving patient quality of life.

Additionally, as per data provided by the publisher, in 2023, the diagnosed prevalence of degenerative disc disease was highest in the US among the 7MM, accounting for nearly 12.91 million cases, which is further expected to increase by 2034. When conservative treatments like physical therapy, medications, and injections fail, spinal fusion surgery becomes a recommended option to stabilize the affected spine segments and alleviate pain, thereby boosting the overall market of spinal fusion devices.

Moreover, the increase in product development activities among the key market players is further boosting the overall market of spinal fusion devices. For instance, in July 2022, Aurora Spine Corporation received the US FDA clearance for its ZIP™ MIS Interspinous Fusion System, indicated for lumbar spinal stenosis.

Therefore, all the factors stated above collectively will drive the spinal fusion device market throughout the forecast period from 2025 to 2032.

However, injury to blood vessels or nerves in and around the spine, causing infections and the presence of alternative procedures such as artificial disc replacement, among others, may prove to be challenging factors for the spinal fusion devices market growth.

Spinal Fusion Devices Market Segment Analysis:

Spinal Fusion Devices Market by Product Type (Thoracolumbar Devices, Cervical Devices, and Interbody Fusion Devices), Indication (Degenerative Disc Disorders, Complex Deformity, Trauma & Fractures, and Others), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the spinal fusion devices market, the interbody fusion devices category is expected to have a significant revenue share in the year 2024. The rapid growth of this product category can be attributed to its essential role in spinal fusion surgeries, where they are used to provide stability and promote the fusion of adjacent vertebrae. They are typically placed between the vertebrae, and these devices support and maintain proper alignment during the healing process.

Key features of interbody fusion devices include their biocompatible materials, like titanium, PEEK, or bioactive ceramics, to minimize rejection risks. These devices come in different designs, like cages, wedges, and blocks, to treat various spine problems. Many of these implants have porous or textured surfaces that help bones grow and fuse better, which also lowers the chance of the body rejecting them. Some devices also have self-locking features that keep them firmly in place once they are implanted. These smart designs make the surgery safer and more effective for different patient needs. Additionally, many are designed for minimally invasive procedures, facilitating quicker recovery and reduced surgical trauma.

In addition, new product approvals are likely to increase the spinal fusion devices market. For instance, in October 2023, NovApproach Spine announced the full market launch of its patented OneLIF™ interbody spinal fusion system, which accommodates various surgical approaches.

Therefore, the presence of a robust product portfolio for the interbody fusion devices category with a wide range of features and applications is expected to witness considerable growth, eventually contributing to the growth of the overall spinal fusion devices market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall spinal fusion devices market:

Among all the regions, North America is estimated to hold the largest revenue share in the spinal fusion devices market in the year 2024. This growth can be attributed to the large patient population suffering from vertebral compression fractures (VCFs) and the rising incidence of chronic pain in the region. The demand is further increased by an aging population and lifestyle-related issues, such as obesity and sedentary habits, which exacerbate spinal conditions. Together, these factors drive the need for the spinal fusion devices market to meet the increasing number of patients requiring surgical intervention for spinal stabilization and pain relief during the forecast period from 2025 to 2032.

According to the National Institute of Health (2023), VCFs are the most frequently reported type of fragility fracture. In the US, approximately 1 to 1.5 million cases of VCFs occur each year. Studies suggested that about 25% of women aged 50 and older would have at least one VCF. Additionally, between 40% and 50% of individuals over the age of 80 were estimated to have experienced a VCF, either as an acute event or discovered incidentally during the evaluation of other health issues. For individuals with VCFs, especially those who are older and may have sustained these fractures either acutely or incidentally, spinal fusion devices help stabilize the affected vertebrae and restore spinal alignment. This stabilization is essential for reducing pain, improving function, and preventing further vertebral collapse.

According to data from the Centers for Disease Control and Prevention (2023), there were 51.6 million US adults who were suffering from chronic pain. In addition to this, 17.1 million individuals had experienced high-impact chronic pain (i.e., chronic pain that results in substantial restriction to daily activities). Moreover, as per data from the Public Health Agency of Canada (2023), 8 million individuals lived with chronic pain in Canada. With the high prevalence of chronic pain in both the United States and Canada, spinal fusion devices are increasingly utilized as a treatment option.

For individuals suffering from chronic pain, especially those with severe cases that significantly restrict daily activities, spinal fusion can provide relief by stabilizing the spine and addressing underlying structural issues. These devices are precious for patients whose chronic pain stems from conditions such as degenerative disc disease, spinal stenosis, or vertebral compression fractures, where conservative treatments have proven ineffective.

Additionally, the increase in product development activities across the region, such as FDA approval, product launch, among others, is further boosting the overall market of spinal fusion devices. For instance, in December 2024, Carlsmed, Inc., a MedTech company specializing in AI-enabled personalized spine surgery, announced that it had received FDA 510(k) clearance for its aprevo® Cervical ACDF Interbody System. This followed the earlier Breakthrough Device designation granted by the FDA for aprevo® technology aimed at treating cervical spine disease. The company’s aprevo® interbody fusion devices for lumbar spine treatment were already available in the U.S. market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the spinal fusion devices market during the forecast period from 2025 to 2032.

Spinal Fusion Devices Market key players:

Some of the key market players operating in the spinal fusion devices market include Zimmer Biomet, Stryker, Medtronic, Orthofix Medical Inc., NuVasive Inc., B. Braun Melsungen AG, XTANT MEDICAL, Globus Medical, ATEC Spine, Inc., Medacta International, Johnson & Johnson Services, Inc., Captiva Spine, Inc., ZAVATION, and others.

Recent Developmental Activities in the Spinal Fusion Devices Market:

• In June 2025, Cerapedics announced the FDA approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, the first and only proven bone growth accelerator for lumbar fusion.
• In April 2025, a recent study confirms the substantial clinical advantages of Neo Medical's Force Control Technology™ in spinal fusion surgery. Findings from a post-market clinical study, published in World Neurosurgery, highlight the notable benefits of this technology in thoracolumbar spinal fusion procedures.
• In December 2024, Neo Medical SA (Neo), a Swiss technology company focused on spine surgery, announced that its entire product portfolio received approval under the European Union’s Medical Device Regulation (MDR) EU 2017/745. This certification confirms the company's compliance with the highest global standards for medical device quality and safety.
• In November 2023, Orthofix Medical Inc. announced that the WaveForm L Lateral Lumbar Interbody System had fully launched commercially in the U.S. This system, designed for lateral lumbar interbody fusion (LLIF) procedures, features a 3D-printed porous structure that emphasizes both strength and stability, creating an optimal environment for spinal fusion.

Key takeaways from the spinal fusion devices market report study

• Market size analysis for the current spinal fusion devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the spinal fusion devices market
• Various opportunities available for the other competitors in the spinal fusion devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current spinal fusion devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the spinal fusion devices market growth in the future?

Target audience who can benefit from this spinal fusion devices market report study

• Spinal fusion devices product providers
• Research organizations and consulting companies
• Spinal fusion device-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in spinal fusion devices
• Various end-users who want to know more about the spinal fusion devices market and the latest technological developments in the spinal fusion devices market

Frequently Asked Questions for the Spinal Fusion Devices Market:

1. What is the spinal fusion devices market?

• Spinal fusion devices connect two or more vertebrae in the spine to improve stability, correct a deformity, or reduce pain.

2. What is the market for spinal fusion devices?

• The spinal fusion devices market was valued at USD 7.13 billion in 2024, growing at a CAGR of 5.31% during the forecast period from 2025 to 2032 to reach USD 10.76 billion by 2032.

3. What are the drivers for the spinal fusion devices market?

• The spinal fusion devices market is experiencing steady growth is driven by the rising instances of spinal disorders along with the growing global prevalence of chronic pain. Additionally, conditions such as degenerative disc disease, spondylolisthesis, and spinal stenosis are becoming increasingly common, particularly among the aging population. The surge in road traffic accidents further highlights the urgent need for effective spinal fusion solutions to restore mobility and reduce long-term disability. Additionally, the increase in product development activities among the key market players is further escalating the overall market of spinal fusion devices. Collectively, these factors are anticipated to fuel the expansion of the spinal fusion devices market over the forecast period from 2025 to 2032.

4. Who are the key players operating in the spinal fusion devices market?

• Some of the key market players operating in the spinal fusion devices market include Zimmer Biomet, Stryker, Medtronic, Orthofix Medical Inc., NuVasive Inc., B. Braun Melsungen AG, XTANT MEDICAL, Globus Medical, ATEC Spine, Inc., Medacta International, Johnson & Johnson Services, Inc., Captiva Spine, Inc., ZAVATION, and others.

5. Which region has the highest share in the spinal fusion devices market?

• Among all the regions, North America is estimated to amass the largest revenue share in the spinal fusion devices market in the year 2024. This growth can be attributed to the large patient population suffering from vertebral compression fractures (VCFs) and the rising incidence of chronic pain in the region. The demand is further increased by an aging population and lifestyle-related issues, such as obesity and sedentary habits, which exacerbate spinal conditions. Together, these factors drive the need for the spinal fusion devices market to meet the increasing number of patients requiring surgical intervention for spinal stabilization and pain relief during the forecast period from 2025 to 2032.

This product will be delivered within 2 business days.